As part of World Antibiotic Awareness Week 2017, we present a Q&A with Mohan P. Joshi, MBBS, MSc, MD, SIAPS principal technical advisor. Dr. Joshi is responsible for providing technical guidance and support in the planning and implementation of rational medicine use and antimicrobial resistance (AMR)-related activities. Are there new AMR threats that are particularly worrying? […]
Archive | AdherenceRSS feed for this section
A presentation by Mohan P. Joshi, Principal Technical Advisor and Lead for Pharmaceutical Services, SIAPS, at USAID in Arlington, VA on November 9 2017.
HIV/TB Pharmaceutical Management Training in Swaziland to Improve Medicine Availability and Rational Use
An off-site training was held for 104 pharmacy personnel (32 males, 72 females) responsible for managing HIV and TB medicines in 88 health facilities in the 4 regions around the country. SIAPS supported the training, which included pharmacists, pharmacy technicians, and nurses. The trainings took place over August 7–17, 2017, and each region was trained […]
Pediatric Antiretroviral Treatment Uptake, Treatment Adherence, Regimen Switches, and Retention in Care in Namibia
In Namibia, a preliminary review of EDT records suggests that children form a small proportion of the patients accessing ART in any given setting, nationally composing 8% of the patients on ART in the MoHSS facilities. Over the years, managing children has been complicated with formulations that have not been friendly for children, complicated regimens, and occasional stock-outs of pediatric ARVs. These challenges may increase the number of children that might receive suboptimal care, including delayed or no interventions in face of poor adherence, ultimately leading to suboptimal response to treatment. This can then increase the risk of HIV drug resistance and leads to short survival of HIV-infected children. Findings from this assessment will provide much needed evidence on trends in pediatric HIV treatment uptake, levels of adherence, and retention among those on treatment. Ultimately, the evidence generated will support MoHSS policy makers and leaders in modifying and strengthening interventions aimed at enhancing treatment uptake, adherence, retention, and viral load suppression among HIV-infected children in Namibia.
By Jane Briggs, Principal Technical Advisor More than 900,000 children die of pneumonia each year (more than malaria, measles, and HIV/AIDS combined), according to the World Health Organization. Many of these cases go undiagnosed and untreated. How can this be when we know what works? A five-day, twice-daily amoxicillin regimen—in either dispersible tablet (DT) or oral […]
With the shift from a disease landscape that focuses on the treatment of acute and short-term illnesses to one that faces an increasing burden of chronic diseases that may require life-long medicine use, the role of medicines in ensuring a healthy population is more important than ever.
However,even when medicines are available, patients may not take them as directed. In other words, they may not adhere to the treatment prescribed to them. This problem is surprisingly widespread. Several studies have estimated that in developed countries, only approximately 50% of patients who suffer from chronic diseases take their medicines as directed.
This document suggests a health systems strengthening (HSS) approach to addressing
medication adherence issues, with a particular emphasis on its application in low- and middle-income settings. Chapter 2 reviews the importance of considering health systems in improving medication adherence and introduces a system-based framework, while Chapters 3–5 discuss approaches, interventions, and activities that span the health system as described at the
macro, meso, and micro levels and provide implementation examples.
Baseline Study Report: Prescription Practices for Antiretroviral Therapy in Comprehensive Care Services of the Dominican Republic
The purpose of this study is to determine if the current prescription practices adhere to the national therapeutic guidelines. Finding notable discrepancies between the prescription practices and the guidelines would explain unjustified expenses in ARV therapy and the stockout problems and overstocks that occasionally occur.
This week, SIAPS joins delegates from all over the globe for the 46th Union World Conference on Lung Health (#WCLH2015), in Cape Town, South Africa. At this year’s conference, SIAPS staff will present at several sessions focusing on how strong pharmaceutical systems support efforts to end TB including increasing access to TB medicines, expanding pharmacovigilance systems, […]
More than 900,000 children die of pneumonia each year. Many of these cases go undiagnosed and untreated. The countdown to 2015 report notes that only 54% of children with pneumonia symptoms are taken to a health care provider, while the Global Action Plan for Pneumonia and Diarrhea reports that only 31% of children with suspected […]
The second in the series, the newly published, SIAPS-authored course on Antimicrobial Resistance expands upon the concepts presented in Part 1 and explains the major factors that contribute to the development and spread of antimicrobial resistance. The course also explores some of the proven interventions and global strategies currently being used to combat AMR, reviews […]
To learn more about SIAPS program activities worldwide, please read our annual report for program year 6.
Project dates: January 2012 – September 2017
- What Gets Defined, Gets Measured: Definitions and a Framework for Measuring Pharmaceutical Systems Strengthening
SIAPS is presenting its webinar “What Gets Defined, Gets Measured: Definitions and a Framework for Measuring Pharmaceutical Systems Strengthening” on […]